PSU Profiles
Keywords
Last Name
Institution

David Goldenberg

TitleProfessor
InstitutionCollege of Medicine
DepartmentSurgery
Address500 University Drive Hershey PA 17033
Phone7175318945
Other Positions
TitleProfessor
InstitutionCollege of Medicine
DepartmentOncology


 Biography 
 awards and honors
2015 - Top Cancer Doctors
2014 - Distinguished Educator Award
2013 - Distinguished Service Award
2013 - Deans Award for Excellence in Teaching
2013 - Top 1% of Physicians
2009 - 2015Best Doctors in America
2009 - 2015America’s Top Doctors for Cancer
2009 - Alpha Omega Alpha

 Overview 
 overview
PREFERRED TITLE/ROLE:



Professor of Surgery and Medicine, Chief of Otolaryngology-Head and Neck Surgery



EDUCATION:



Fellowship, Head & Neck Oncology and Surgery: The Johns Hopkins University Hospital, Baltimore (2005)

Residency, Rambam Medical Center, Haifa Israel (2002)

Internship, Soroka Medical Center, Beer Sheva Israel (1996)

M.D., Ben Gurion University of the Negev,Beer Sheva Israel (1994)



NARRATIVE:



David Goldenberg is a Head and Neck Surgical Oncologist. He was educated at the Ben Gurion University in Israel. He completed a residency in Otolaryngology-Head and Neck Surgery at Rambam Medical Center in Haifa, Israel and then went on to do a three year fellowship in Head and Neck Surgery and Oncology at the Johns Hopkins Hospital in Baltimore. Currently a tenured Professor of both Surgery and Medicine at the Penn State College of Medicine, he is the Chief of Otolaryngology- Head and Neck Surgery at the Penn State Hershey Medical Center and Associate Director of Surgery at the Penn State Cancer Institute in Hershey, PA. He combines a surgical practice with teaching and research in head and neck and thyroid malignancies.



Clinical expertise is in the surgical care of patients with head and neck cancer, thyroid cancer as well as parathyroid disease. Dr. Goldenberg is one of the only head and neck surgeon in the region performing Da Vinci TransOral Robotic Surgery (TORS) and Minimally invasive radioguided parathyroidecotmy (MIRP).



Research: Dr. Goldenberg is a funded researcher and a prolific author of articles and books in the field of head and neck and thyroid oncology and surgery.


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Bann DV, Kim Y, Zacharia T, Goldenberg D. The Effect of Aging on the Anatomic Position of the Thyroid Gland. Clin Anat. 2016 Oct 28.
    View in: PubMed
  2. Ow TJ, Wang HR, McLellan B, Ciocon D, Amin B, Goldenberg D, Schmalbach CE. AHNS series - Do you know your guidelines? Diagnosis and management of cutaneous squamous cell carcinoma. Head Neck. 2016 Nov; 38(11):1589-1595.
    View in: PubMed
  3. Liebman HA, Saleh MN, Bussel JB, Negrea OG, Horne H, Wegener WA, Goldenberg DM. Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia. Haematologica. 2016 Nov; 101(11):1327-1332.
    View in: PubMed
  4. Abdulghani J, Gokare P, Gallant JN, Dicker D, Whitcomb T, Cooper T, Liao J, Derr J, Liu J, Goldenberg D, Finnberg NK, El-Deiry WS. Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC). Clin Cancer Res. 2016 Jun 15.
    View in: PubMed
  5. Downey J, Friedman RC, Haase E, Goldenberg D, Bell R, Edsall S. Comparison of Sexual Experience and Behavior between Bipolar Outpatients and Outpatients without Mood Disorders. Psychiatry J. 2016; 2016:5839181.
    View in: PubMed
  6. Harounian JA, Goldenberg D, May JG. The rare fourth branchial cleft anomaly. Ear Nose Throat J. 2016 Apr-May; 95(4-5):154-6.
    View in: PubMed
  7. Gooi Z, Fakhry C, Goldenberg D, Richmon J, Kiess AP. AHNS Series: Do you know your guidelines?Principles of radiation therapy for head and neck cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2016 Jul; 38(7):987-92.
    View in: PubMed
  8. Gross ND, Holsinger FC, Magnuson JS, Duvvuri U, Genden EM, Ghanem TA, Yaremchuk KL, Goldenberg D, Miller MC, Moore EJ, Morris LG, Netterville J, Weinstein GS, Richmon J. Robotics in otolaryngology and head and neck surgery: Recommendations for training and credentialing: A report of the 2015 AHNS education committee, AAO-HNS robotic task force and AAO-HNS sleep disorders committee. Head Neck. 2016 Apr; 38 Suppl 1:E151-8.
    View in: PubMed
  9. Enomoto LM, Bann DV, Hollenbeak CS, Goldenberg D. Trends in the Incidence of Oropharyngeal Cancers in the United States. Otolaryngol Head Neck Surg. 2016 Jun; 154(6):1034-40.
    View in: PubMed
  10. Miller MC, Goldenberg D. Do you know your guidelines? An initiative of the American Head and Neck Society's Education Committee. Head Neck. 2016 Feb; 38(2):165-7.
    View in: PubMed
  11. Roman BR, Goldenberg D, Givi B. AHNS Series--Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors. Head Neck. 2016 Feb; 38(2):168-74.
    View in: PubMed
  12. Pachuski J, Vaida S, Donahue K, Roberts J, Kunselman A, Oberman B, Patel H, Goldenberg D. Effect of laryngotracheal topical anesthesia on recurrent laryngeal nerve monitoring during thyroid Surgery. J Clin Anesth. 2016 Mar; 29:10-3.
    View in: PubMed
  13. Hennessy M, Goldenberg D. The Role of Prophylactic Central Neck Dissection in the Treatment of Differentiated Thyroid Cancer. Rambam Maimonides Med J. 2016; 7(1).
    View in: PubMed
  14. Bann DV, Goldenberg D. Four cystic parathyroid adenomas in a 71-year-old man. Ear Nose Throat J. 2016 Jan; 95(1):21-2.
    View in: PubMed
  15. Magister MJ, Goldenberg D. Caution Against Overinvestigation of Small Thyroid Nodules--Reply. JAMA Otolaryngol Head Neck Surg. 2016 Jan; 142(1):103.
    View in: PubMed
  16. Miles BA, Goldenberg D. Merkel cell carcinoma: Do you know your guidelines? Head Neck. 2016 May; 38(5):647-52.
    View in: PubMed
  17. Magister MJ, Chaikhoutdinov I, Schaefer E, Williams N, Saunders B, Goldenberg D. Association of Thyroid Nodule Size and Bethesda Class With Rate of Malignant Disease. JAMA Otolaryngol Head Neck Surg. 2015 Dec; 141(12):1089-95.
    View in: PubMed
  18. Enomoto LM, Schaefer EW, Goldenberg D, Mackley H, Koch WM, Hollenbeak CS. The Cost of Hospice Services in Terminally Ill Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2015 Dec; 141(12):1066-74.
    View in: PubMed
  19. Faltas B, Goldenberg DM, Ocean AJ, Govindan SV, Wilhelm F, Sharkey RM, Hajdenberg J, Hodes G, Nanus DM, Tagawa ST. Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma. Clin Genitourin Cancer. 2016 Feb; 14(1):e75-9.
    View in: PubMed
  20. Saadi R, Goldenberg D. An intrathyroidal thyroglossal duct cyst. Ear Nose Throat J. 2015 Oct-Nov; 94(10-11):446-7.
    View in: PubMed
  21. Setabutr D, Vakharia K, Nogan SJ, Kamel GN, Allen T, Saunders BD, Goldenberg D. Comparison of SPECT/CT and planar MIBI in terms of operating time and cost in the surgical management of primary hyperparathyroidism. Ear Nose Throat J. 2015 Oct-Nov; 94(10-11):448-52.
    View in: PubMed
  22. Portela RA, Choby GW, Manni A, Campbell D, Crist H, Goldenberg D. Unusual sites of metastasis of papillary thyroid cancer: Case series and review of the literature. Ear Nose Throat J. 2015 Aug; 94(8):E43-7.
    View in: PubMed
  23. Picozzi VJ, Ramanathan RK, Lowery MA, Ocean AJ, Mitchel EP, O'Neil BH, Guarino MJ, Conkling PR, Cohen SJ, Bahary N, Frank RC, Dragovich T, Bridges BB, Braiteh FS, Starodub AN, Lee FC, Gribbin TE, Richards DA, Lee M, Korn RL, Pandit-Taskar N, Goldsmith SJ, Intenzo CM, Sheikh A, Manzone TC, Horne H, Sharkey RM, Wegener WA, O'Reilly EM, Goldenberg DM, Von Hoff DD. (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Eur J Cancer. 2015 Sep; 51(14):1857-64.
    View in: PubMed
  24. Hollenbeak CS, Kulaylat AN, Mackley H, Koch W, Schaefer EW, Goldenberg D. Determinants of Medicare Costs for Elderly Patients With Oral Cavity and Pharyngeal Cancers. JAMA Otolaryngol Head Neck Surg. 2015 Jul; 141(7):628-35.
    View in: PubMed
  25. Sharkey RM, McBride WJ, Cardillo TM, Govindan SV, Wang Y, Rossi EA, Chang CH, Goldenberg DM. Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan). Clin Cancer Res. 2015 Nov 15; 21(22):5131-8.
    View in: PubMed
  26. Davies L, Morris LG, Haymart M, Chen AY, Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong RJ, Randolph G. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. Endocr Pract. 2015 Jun; 21(6):686-96.
    View in: PubMed
  27. Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Arrojo R, Liu D, Rossi EA, Chang CH, Goldenberg DM. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug Chem. 2015 May 20; 26(5):919-31.
    View in: PubMed
  28. Starodub AN, Ocean AJ, Shah MA, Guarino MJ, Picozzi VJ, Vahdat LT, Thomas SS, Govindan SV, Maliakal PP, Wegener WA, Hamburger SA, Sharkey RM, Goldenberg DM. First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors. Clin Cancer Res. 2015 Sep 1; 21(17):3870-8.
    View in: PubMed
  29. Christian BA, Poi M, Jones JA, Porcu P, Maddocks K, Flynn JM, Benson DM, Phelps MA, Wei L, Byrd JC, Wegener WA, Goldenberg DM, Baiocchi RA, Blum KA. The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma. Br J Haematol. 2015 Jun; 169(5):701-10.
    View in: PubMed
  30. Bann DV, Zacharia T, Goldenberg D, Goyal N. Parathyroid localization using 4D-computed tomography. Ear Nose Throat J. 2015 Apr-May; 94(4-5):E55-7.
    View in: PubMed
  31. Williams MU, Carr MM, Goldenberg D. Public awareness of human papillomavirus as a causative factor for oropharyngeal cancer. Otolaryngol Head Neck Surg. 2015 Jun; 152(6):1029-34.
    View in: PubMed
  32. Oberman B, Khaku A, Camacho F, Goldenberg D. Relationship between obesity, diabetes and the risk of thyroid cancer. Am J Otolaryngol. 2015 Jul-Aug; 36(4):535-41.
    View in: PubMed
  33. Raetz EA, Cairo MS, Borowitz MJ, Lu X, Devidas M, Reid JM, Goldenberg DM, Wegener WA, Zeng H, Whitlock JA, Adamson PC, Hunger SP, Carroll WL. Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2. Pediatr Blood Cancer. 2015 Jul; 62(7):1171-5.
    View in: PubMed
  34. Sharma J, Goldenberg D, Crist H, McGinn J. Multifocal inverted papillomas in the head and neck. Ear Nose Throat J. 2015 Mar; 94(3):E20-3.
    View in: PubMed
  35. Liu D, Chang CH, Gold DV, Goldenberg DM. Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer. Oncotarget. 2015 Feb 28; 6(6):4274-85.
    View in: PubMed
  36. Woliner-van der Weg W, Schoffelen R, Hobbs RF, Gotthardt M, Goldenberg DM, Sharkey RM, Slump CH, van der Graaf WT, Oyen WJ, Boerman OC, Sgouros G, Visser EP. Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy. EJNMMI Phys. 2015 Dec; 2(1):5.
    View in: PubMed
  37. Goyal N, Goldenberg D. Reply to letter to the editor regarding course of lingual artery. Head Neck. 2015 Mar; 37(3):461-2.
    View in: PubMed
  38. Patel HH, Siltumens A, Bess L, Camacho F, Goldenberg D. The decline of tracheotomy among otolaryngologists: a 14-year review. Otolaryngol Head Neck Surg. 2015 Mar; 152(3):465-9.
    View in: PubMed
  39. Roman BR, Patel SG, Wang MB, Pou AM, Holsinger FC, Myssiorek D, Goldenberg D, Swisher-McClure S, Lin A, Shah JP, Shea JA. Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer. J Natl Compr Canc Netw. 2015 Jan; 13(1):69-77.
    View in: PubMed
  40. Goldenberg D, Goyal N. Impact factor: what is it and is it still relevant? Ear Nose Throat J. 2015 Jan; 94(1):14-16, 19.
    View in: PubMed
  41. Adil E, Setabutr D, Ghossaini SN, Goldenberg D. Metastatic squamous cell carcinoma of the tonsil presenting as otorrhea: a case report. Ear Nose Throat J. 2015 Jan; 94(1):E7-9.
    View in: PubMed
  42. Bann DV, Goyal N, Camacho F, Goldenberg D. Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania. JAMA Otolaryngol Head Neck Surg. 2014 Dec; 140(12):1149-56.
    View in: PubMed
  43. Payne SJ, Smucker JE, Bruno MA, Winner LS, Saunders BD, Goldenberg D. Radiographic evaluation of non-localizing parathyroid adenomas. Am J Otolaryngol. 2015 Mar-Apr; 36(2):217-22.
    View in: PubMed
  44. Bann DV, Goyal N, Crist H, Goldenberg D. Black thyroid. Ear Nose Throat J. 2014 Oct-Nov; 93(10-11):E54-5.
    View in: PubMed
  45. Goldenberg DM, Rooney RJ, Loo M, Liu D, Chang CH. In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA. PLoS One. 2014; 9(9):e107927.
    View in: PubMed
  46. Lütje S, Rijpkema M, Goldenberg DM, van Rij CM, Sharkey RM, McBride WJ, Franssen GM, Frielink C, Helfrich W, Oyen WJ, Boerman OC. Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer. Cancer Res. 2014 Nov 1; 74(21):6216-23.
    View in: PubMed
  47. Witzig TE, Tomblyn MB, Misleh JG, Kio EA, Sharkey RM, Wegener WA, Goldenberg DM. Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma. Haematologica. 2014 Nov; 99(11):1738-45.
    View in: PubMed
  48. Goldenberg D, Mackley H, Koch W, Bann DV, Schaefer EW, Hollenbeak CS. Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly. Oral Oncol. 2014 Oct; 50(10):976-82.
    View in: PubMed
  49. Rossi EA, Rossi DL, Cardillo TM, Chang CH, Goldenberg DM. Redirected T-cell killing of solid cancers targeted with an anti-CD3/Trop-2-bispecific antibody is enhanced in combination with interferon-a. Mol Cancer Ther. 2014 Oct; 13(10):2341-51.
    View in: PubMed
  50. Goyal N, Camacho F, Mangano J, Goldenberg D. Evaluating for a geospatial relationship between radon levels and thyroid cancer in Pennsylvania. Laryngoscope. 2015 Jan; 125(1):E45-9.
    View in: PubMed
  51. Patel HH, Goyal N, Goldenberg D. Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer. Ann Med. 2014 Sep; 46(6):409-16.
    View in: PubMed
  52. Bann DV, Goyal N, Goldenberg D. Papillary thyroid cancer in a gravid woman. Ear Nose Throat J. 2014 Jul; 93(7):252-4.
    View in: PubMed
  53. Sgouros G, Goldenberg DM. Radiopharmaceutical therapy in the era of precision medicine. Eur J Cancer. 2014 Sep; 50(13):2360-3.
    View in: PubMed
  54. Schaefer EW, Wilson MZ, Goldenberg D, Mackley H, Koch W, Hollenbeak CS. Effect of marriage on outcomes for elderly patients with head and neck cancer. Head Neck. 2015 May; 37(5):735-42.
    View in: PubMed
  55. Salaun PY, Campion L, Ansquer C, Frampas E, Mathieu C, Robin P, Bournaud C, Vuillez JP, Taieb D, Rousseau C, Drui D, Mirallié E, Borson-Chazot F, Goldenberg DM, Chatal JF, Barbet J, Kraeber-Bodéré F. ¹8F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2014 Aug; 41(8):1501-10.
    View in: PubMed
  56. Shah S, Goldenberg D. Robotic surgery for oropharyngeal cancer. Rambam Maimonides Med J. 2014 Apr; 5(2):e0014.
    View in: PubMed
  57. Bann DV, Goyal N, Goldenberg D. Parathyroid adenoma in a woman with secondary hyperparathyroidism. Ear Nose Throat J. 2014 Apr-May; 93(4-5):158, 160.
    View in: PubMed
  58. Chaikhoutdinov I, Mitzner R, Goldenberg D. Incidental Thyroid Nodules: Incidence, Evaluation, and Outcome. Otolaryngol Head Neck Surg. 2014 Jun; 150(6):939-42.
    View in: PubMed
  59. Shi C, Merchant N, Newsome G, Goldenberg DM, Gold DV. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. Arch Pathol Lab Med. 2014 Feb; 138(2):220-8.
    View in: PubMed
  60. Goyal N, Yoo F, Setabutr D, Goldenberg D. Surgical anatomy of the supraglottic larynx using the da Vinci robot. Head Neck. 2014 Aug; 36(8):1126-31.
    View in: PubMed
  61. Strand V, Petri M, Kalunian K, Gordon C, Wallace DJ, Hobbs K, Kelley L, Kilgallen B, Wegener WA, Goldenberg DM. Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006. Rheumatology (Oxford). 2014 Mar; 53(3):502-11.
    View in: PubMed
  62. Oberman B, Setabutr D, Goldenberg D. Traumatic dislocation of intact mandibular condyle into middle cranial fossa. Am J Otolaryngol. 2014 Mar-Apr; 35(2):251-3.
    View in: PubMed
  63. Yoo F, Chaikhoutdinov I, Mitzner R, Liao J, Goldenberg D. Characteristics of incidentally discovered thyroid cancer. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1181-6.
    View in: PubMed
  64. Malloy KM, Ellender SM, Goldenberg D, Dolan RW. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons. JAMA Otolaryngol Head Neck Surg. 2013 Oct; 139(10):1037-42.
    View in: PubMed
  65. Lynch MC, Baker A, Drabick JJ, Williams N, Goldenberg D. Extraskeletal Ewing's sarcoma arising in the larynx. Head Neck Pathol. 2014 Jun; 8(2):225-8.
    View in: PubMed
  66. Abdulghani J, Allen JE, Dicker DT, Liu YY, Goldenberg D, Smith CD, Humphreys R, El-Deiry WS. Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis. PLoS One. 2013; 8(9):e75414.
    View in: PubMed
  67. Boltz MM, Hollenbeak CS, Schaefer E, Goldenberg D, Saunders BD. Attributable costs of differentiated thyroid cancer in the elderly Medicare population. Surgery. 2013 Dec; 154(6):1363-9; discussion 1369-70.
    View in: PubMed
  68. Goyal N, Setabutr D, Goldenberg D. Transoral robotic study of the vascular anatomy of the head and neck. J Robot Surg. 2014 Mar; 8(1):57-61.
    View in: PubMed
  69. Crist HS, Evans JJ, Mani H, Saunders B, Fornadley J, Camacho F, Goldenberg D. Do black (dark) lymph-node metastases in papillary thyroid carcinoma suggest more advanced or aggressive disease? Thyroid. 2013 Aug; 23(8):977-81.
    View in: PubMed
  70. Liebman HA, Saleh MN, Bussel JB, Negrea OG, Horne H, Wegener WA, Goldenberg DM. Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. Br J Haematol. 2013 Sep; 162(5):693-701.
    View in: PubMed
  71. Wallace DJ, Gordon C, Strand V, Hobbs K, Petri M, Kalunian K, Houssiau F, Tak PP, Isenberg DA, Kelley L, Kilgallen B, Barry AN, Wegener WA, Goldenberg DM. Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up. Rheumatology (Oxford). 2013 Jul; 52(7):1313-22.
    View in: PubMed
  72. Hollenbeak CS, Boltz MM, Schaefer EW, Saunders BD, Goldenberg D. Recurrence of differentiated thyroid cancer in the elderly. Eur J Endocrinol. 2013 Apr; 168(4):549-56.
    View in: PubMed
  73. Ho Y, Carr MM, Goldenberg D. Trends in intraoperative neural monitoring for thyroid and parathyroid surgery amongst otolaryngologists and general surgeons. Eur Arch Otorhinolaryngol. 2013 Sep; 270(9):2525-30.
    View in: PubMed
  74. Goyal N, Setabutr D, Abdulghani J, Goldenberg D. Molecular and genetic markers of follicular-cell thyroid cancer: etiology and diagnostic and therapeutic opportunities. Adv Exp Med Biol. 2013; 779:309-26.
    View in: PubMed
  75. Chaikhoutdinov I, Goldenberg D. Impact of genetic targets on therapy in head and neck squamous cell carcinoma. Adv Exp Med Biol. 2013; 779:165-77.
    View in: PubMed
  76. Baker AR, Ohanessian SE, Adil E, Crist HS, Goldenberg D, Mani H. Dedifferentiated epithelial-myoepithelial carcinoma: analysis of a rare entity based on a case report and literature review. Int J Surg Pathol. 2013 Oct; 21(5):514-9.
    View in: PubMed
  77. Warshafsky D, Goldenberg D, Kanekar SG. Imaging anatomy of deep neck spaces. Otolaryngol Clin North Am. 2012 Dec; 45(6):1203-21.
    View in: PubMed
  78. Chen X, Chang CH, Stein R, Cardillo TM, Gold DV, Goldenberg DM. Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab. Biol Blood Marrow Transplant. 2013 Jan; 19(1):28-39.
    View in: PubMed
  79. Sharkey RM, van Rij CM, Karacay H, Rossi EA, Frielink C, Regino C, Cardillo TM, McBride WJ, Chang CH, Boerman OC, Goldenberg DM. A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers. J Nucl Med. 2012 Oct; 53(10):1625-32.
    View in: PubMed
  80. Chang SS, Goldenberg D, Koch WM. Transcervical approach to benign parapharyngeal space tumors. Ann Otol Rhinol Laryngol. 2012 Sep; 121(9):620-4.
    View in: PubMed
  81. Goyal N, Zacharia TT, Goldenberg D. Differentiation of branchial cleft cysts and malignant cystic adenopathy of pharyngeal origin. AJR Am J Roentgenol. 2012 Aug; 199(2):W216-21.
    View in: PubMed
  82. Evans JJ, Crist HS, Durvesh S, Bruggeman RD, Goldenberg D. A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma. Cancer Biol Ther. 2012 Jul; 13(9):776-81.
    View in: PubMed
  83. Garritano FG, Goldenberg D. Telemedicine in otolaryngology-head and neck surgery. Ear Nose Throat J. 2012 Jun; 91(6):226-9.
    View in: PubMed
  84. Ocean AJ, Pennington KL, Guarino MJ, Sheikh A, Bekaii-Saab T, Serafini AN, Lee D, Sung MW, Gulec SA, Goldsmith SJ, Manzone T, Holt M, O'Neil BH, Hall N, Montero AJ, Kauh J, Gold DV, Horne H, Wegener WA, Goldenberg DM. Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial. Cancer. 2012 Nov 15; 118(22):5497-506.
    View in: PubMed
  85. Goyal N, Camacho F, Mangano J, Goldenberg D. Thyroid cancer characteristics in the population surrounding Three Mile Island. Laryngoscope. 2012 Jun; 122(6):1415-21.
    View in: PubMed
  86. Goldenberg DM. Horizontal transmission of malignancy by cell-cell fusion. Expert Opin Biol Ther. 2012 Jun; 12 Suppl 1:S133-9.
    View in: PubMed
  87. Taylor AP, Makabi-Panzu B, Chen X, Gold DV, Goldenberg DM. Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic mice. Hum Immunol. 2012 Jun; 73(6):612-9.
    View in: PubMed
  88. Stack BC, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S, Sosa JA, Tufano RP. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012 May; 22(5):501-8.
    View in: PubMed
  89. Sharkey RM, Chang CH, Rossi EA, McBride WJ, Goldenberg DM. Pretargeting: taking an alternate route for localizing radionuclides. Tumour Biol. 2012 Jun; 33(3):591-600.
    View in: PubMed
  90. Adil E, Setabutr D, Mikesell K, Goldenberg D. Hyalinizing clear cell adenocarcinoma of the oropharynx. Head Neck. 2013 Jun; 35(6):E184-6.
    View in: PubMed
  91. Alinari L, Mahoney E, Patton J, Zhang X, Huynh L, Earl CT, Mani R, Mao Y, Yu B, Quinion C, Towns WH, Chen CS, Goldenberg DM, Blum KA, Byrd JC, Muthusamy N, Praetorius-Ibba M, Baiocchi RA. FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death. Blood. 2011 Dec 22; 118(26):6893-903.
    View in: PubMed
  92. Garritano FG, Goldenberg D. Successful telemedicine programs in otolaryngology. Otolaryngol Clin North Am. 2011 Dec; 44(6):1259-74, vii.
    View in: PubMed
  93. Tashima L, Mitzner R, Durvesh S, Goldenberg D. Dyspnea as a prognostic factor in anaplastic thyroid carcinoma. Eur Arch Otorhinolaryngol. 2012 Apr; 269(4):1251-5.
    View in: PubMed
  94. Rossi EA, Rossi DL, Cardillo TM, Stein R, Goldenberg DM, Chang CH. Preclinical studies on targeted delivery of multiple IFNa2b to HLA-DR in diverse hematologic cancers. Blood. 2011 Aug 18; 118(7):1877-84.
    View in: PubMed
  95. Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, Chang S, Brait M, Jiang WW, Kim MM, Claybourne Q, Goldenberg D, Khan Z, Khan T, Westra WH, Sidransky D, Koch W, Califano JA. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res. 2011 Jul 15; 17(14):4782-9.
    View in: PubMed
  96. Karacay H, Sharkey RM, McBride WJ, Rossi EA, Chang CH, Goldenberg DM. Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68Ga. J Nucl Med. 2011 Apr; 52(4):555-9.
    View in: PubMed
  97. Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Goldenberg DM. Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. Clin Cancer Res. 2011 May 15; 17(10):3157-69.
    View in: PubMed
  98. Sohrabi S, Drabick JJ, Crist H, Goldenberg D, Sheehan JM, Mackley HB. Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature. J Clin Oncol. 2011 May 1; 29(13):e358-61.
    View in: PubMed
  99. Alinari L, Yu B, Christian BA, Yan F, Shin J, Lapalombella R, Hertlein E, Lustberg ME, Quinion C, Zhang X, Lozanski G, Muthusamy N, Prætorius-Ibba M, O'Connor OA, Goldenberg DM, Byrd JC, Blum KA, Baiocchi RA. Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma. Blood. 2011 Apr 28; 117(17):4530-41.
    View in: PubMed
  100. Hollenbeak CS, Wang L, Schneider P, Goldenberg D. Outcomes of thyroid cancer in African Americans. Ethn Dis. 2011; 21(2):210-5.
    View in: PubMed
  101. Choby G, Goldenberg D. The history of tracheotomy. Pharos Alpha Omega Alpha Honor Med Soc. 2011; 74(3):34-8.
    View in: PubMed
  102. Negrea GO, Elstrom R, Allen SL, Rai KR, Abbasi RM, Farber CM, Teoh N, Horne H, Wegener WA, Goldenberg DM. Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphoma. Haematologica. 2011 Apr; 96(4):567-73.
    View in: PubMed
  103. Gold DV, Stein R, Burton J, Goldenberg DM. Enhanced expression of CD74 in gastrointestinal cancers and benign tissues. Int J Clin Exp Pathol. 2010 Nov 23; 4(1):1-12.
    View in: PubMed
  104. Newhouse E, Ondik MP, Carr M, Goldenberg D. Who is performing percutaneous tracheotomies? Practice patterns of surgeons in the USA. Eur Arch Otorhinolaryngol. 2011 Mar; 268(3):415-8.
    View in: PubMed
  105. Goldenberg D. Percutaneous tracheotomy and otolaryngology: perceptions, trends and educational implications for our profession. Clin Otolaryngol. 2010 Oct; 35(5):445-6.
    View in: PubMed
  106. Goldenberg D, Ondik MP. DaVinci robot-assisted transcervical excision of a parapharyngeal space tumor. J Robot Surg. 2010 Sep; 4(3):197-9.
    View in: PubMed
  107. Gupta P, Goldenberg DM, Rossi EA, Chang CH. Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias. Blood. 2010 Oct 28; 116(17):3258-67.
    View in: PubMed
  108. Ondik MP, McGinn J, Ruggiero F, Goldenberg D. Unintentional parathyroidectomy and hypoparathyroidism in secondary central compartment surgery for thyroid cancer. Head Neck. 2010 Apr; 32(4):462-6.
    View in: PubMed
  109. Mitchell RM, Eisele DW, Mitzner R, Goldenberg D. The tracheotomy punch for urgent tracheotomy. Laryngoscope. 2010 Apr; 120(4):745-8.
    View in: PubMed
  110. Choby G, Trojanowski A, Johnson S, Goldenberg D. Use of double electrode pads for intraoperative monitoring of the recurrent laryngeal nerve. Ann Otol Rhinol Laryngol. 2010 Apr; 119(4):233-5.
    View in: PubMed
  111. Choby G, Hollenbeak CS, Johnson S, Goldenberg D. Surface electrode recurrent laryngeal nerve monitoring during thyroid surgery: normative values. J Clin Neurophysiol. 2010 Feb; 27(1):34-7.
    View in: PubMed
  112. Pistrio A , Goldenberg D. Current Radiopharmaceuticals. CT-MIBI-SPECT Fusion Imaging Combined with Gamma Probe for. 2010; 3:263-266.
  113. Mitchell RM, Eisele DW, Goldenberg D. The tracheotomy punch for urgent tracheotomy. Laryngoscope. 2010; 120 Suppl 4:S198.
    View in: PubMed
  114. Goldenberg DM, Sharkey RM. Radioactive antibodies: a historical review of selective targeting and treatment of cancer. Hosp Pract (1995). 2010; 38(3):82-93.
    View in: PubMed
  115. Poeta ML, Manola J, Goldenberg D, Forastiere A, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM. The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins. Clin Cancer Res. 2009 Dec 15; 15(24):7658-7665.
    View in: PubMed
  116. McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. BMC Cancer. 2009; 9:369.
    View in: PubMed
  117. Ondik MP, Dezfoli S, Lipinski L, Ruggiero F, Goldenberg D. Secondary central compartment surgery for thyroid cancer. Laryngoscope. 2009 Oct; 119(10):1947-50.
    View in: PubMed
  118. Govindan SV, Cardillo TM, Moon SJ, Hansen HJ, Goldenberg DM. CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates. Clin Cancer Res. 2009 Oct 1; 15(19):6052-61.
    View in: PubMed
  119. Pichardo-Lowden A, Durvesh S, Douglas S, Todd W, Bruno M, Goldenberg D. Anaplastic thyroid carcinoma in a young woman: a rare case of survival. Thyroid. 2009 Jul; 19(7):775-9.
    View in: PubMed
  120. Adil E, Adil T, Fedok F, Kauffman G, Goldenberg D. Minimally invasive radioguided parathyroidectomy performed for primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2009 Jul; 141(1):34-8.
    View in: PubMed
  121. Modrak DE, Leon E, Goldenberg DM, Gold DV. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines. Mol Cancer Res. 2009 Jun; 7(6):890-6.
    View in: PubMed
  122. Goldenberg D, Brooksby C, Hollenbeak CS. Age as a determinant of outcomes for patients with oral cancer. Oral Oncol. 2009 Aug; 45(8):e57-61.
    View in: PubMed
  123. Stein R, Smith MR, Chen S, Zalath M, Goldenberg DM. Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines. Clin Cancer Res. 2009 Apr 15; 15(8):2808-17.
    View in: PubMed
  124. Mattes MJ, Michel RB, Goldenberg DM, Sharkey RM. Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap. Cancer Biother Radiopharm. 2009 Apr; 24(2):185-93.
    View in: PubMed
  125. Sharkey RM, Karacay H, Johnson CR, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma. J Nucl Med. 2009 Mar; 50(3):444-53.
    View in: PubMed
  126. Goldenberg D, Park SS, Carr M. Percutaneous tracheotomy in otolaryngology-head and neck surgery residency training programs. Laryngoscope. 2009 Feb; 119(2):289-92.
    View in: PubMed
  127. Cheung EJ, Wagner H, Botti JJ, Fedok F, Goldenberg D. Advanced oral tongue cancer in a 22-year-old pregnant woman. Ann Otol Rhinol Laryngol. 2009 Jan; 118(1):21-6.
    View in: PubMed
  128. Johnson S, Goldenberg D. Intraoperative monitoring of the recurrent laryngeal nerve during revision thyroid surgery. Otolaryngol Clin North Am. 2008 Dec; 41(6):1147-54, ix.
    View in: PubMed
  129. Ort S, Goldenberg D. Management of regional metastases in well-differentiated thyroid cancer. Otolaryngol Clin North Am. 2008 Dec; 41(6):1207-18, xi.
    View in: PubMed
  130. Ondik MP, Tulchinsky M, Goldenberg D. Radioguided reoperative thyroid and parathyroid surgery. Otolaryngol Clin North Am. 2008 Dec; 41(6):1185-98, x.
    View in: PubMed
  131. Goldenberg D. Preface. Revision endocrine surgery of the head and neck. Otolaryngol Clin North Am. 2008 Dec; 41(6):xv-xvi.
    View in: PubMed
  132. Sharkey RM, Goldenberg DM. Novel radioimmunopharmaceuticals for cancer imaging and therapy. Curr Opin Investig Drugs. 2008 Dec; 9(12):1302-16.
    View in: PubMed
  133. Leonard JP, Schuster SJ, Emmanouilides C, Couture F, Teoh N, Wegener WA, Coleman M, Goldenberg DM. Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma. Cancer. 2008 Nov 15; 113(10):2714-23.
    View in: PubMed
  134. Goldenberg D, Zagon IS, Fedok F, Crist HS, McLaughlin PJ. Expression of opioid growth factor (OGF)-OGF receptor (OGFr) axis in human nonmedullary thyroid cancer. Thyroid. 2008 Nov; 18(11):1165-70.
    View in: PubMed
  135. Ondik MP, Kang J, Bayerl MG, Bruno M, Goldenberg D. Teflon laryngeal granuloma presenting as laryngeal cancer on combined positron emission tomography and computed tomography scanning. J Laryngol Otol. 2009 May; 123(5):575-8.
    View in: PubMed
  136. Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Wang Y, Chang CH. Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics. Cancer Res. 2008 Oct 15; 68(20):8384-92.
    View in: PubMed
  137. Mattes MJ, Sharkey RM, Karacay H, Czuczman MS, Goldenberg DM. Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab). Clin Cancer Res. 2008 Oct 1; 14(19):6154-60.
    View in: PubMed
  138. Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC. Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. J Clin Oncol. 2008 Aug 1; 26(22):3756-62.
    View in: PubMed
  139. Agrawal N, Goldenberg D. Primary and salvage total laryngectomy. Otolaryngol Clin North Am. 2008 Aug; 41(4):771-80, vii.
    View in: PubMed
  140. Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, Califano JA, Tufano RP, Koch WM. Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck. 2008 Jul; 30(7):898-903.
    View in: PubMed
  141. Sharkey RM, Karacay H, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody. Cancer Res. 2008 Jul 1; 68(13):5282-90.
    View in: PubMed
  142. Gold DV, Goldenberg DM, Karacay H, Rossi EA, Chang CH, Cardillo TM, McBride WJ, Sharkey RM. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma. Cancer Res. 2008 Jun 15; 68(12):4819-26.
    View in: PubMed
  143. Goldenberg D. Announcing the otolaryngology-head and neck surgery section of the Medscape Journal of Medicine. Medscape J Med. 2008; 10(4):104.
    View in: PubMed
  144. Mattes MJ, Goldenberg DM. Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons. Eur J Nucl Med Mol Imaging. 2008 Jul; 35(7):1249-58.
    View in: PubMed
  145. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, Chang S, Brait M, Nayak CS, Jiang WW, Claybourne Q, Tokumaru Y, Lee J, Goldenberg D, Garrett-Mayer E, Goodman S, Moon CS, Koch W, Westra WH, Sidransky D, Califano JA. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res. 2008 Jan 1; 14(1):97-107.
    View in: PubMed
  146. Gold DV, Karanjawala Z, Modrak DE, Goldenberg DM, Hruban RH. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Clin Cancer Res. 2007 Dec 15; 13(24):7380-7.
    View in: PubMed
  147. Goldenberg DM, Rossi EA, Sharkey RM, McBride WJ, Chang CH. Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting. J Nucl Med. 2008 Jan; 49(1):158-63.
    View in: PubMed
  148. Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM. CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5556s-5563s.
    View in: PubMed
  149. Chang CH, Rossi EA, Goldenberg DM. The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5586s-5591s.
    View in: PubMed
  150. Brard PY, Karacay H, Stein R, Sharkey RM, Mattes MJ, Chang CH, Rossi EA, McBride WJ, Goldenberg DM. A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5564s-5571s.
    View in: PubMed
  151. Scurry WC, Goldenberg D, Chee MY, Lengerich EJ, Liu Y, Fedok FG. Regional recurrence of squamous cell carcinoma of the nasal cavity: a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg. 2007 Aug; 133(8):796-800.
    View in: PubMed
  152. Bhatti N, Tatlipinar A, Mirski M, Koch WM, Goldenberg D. Percutaneous dilation tracheotomy in intensive care unit patients. Otolaryngol Head Neck Surg. 2007 Jun; 136(6):938-41.
    View in: PubMed
  153. Leonard JP, Goldenberg DM. Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies. Oncogene. 2007 May 28; 26(25):3704-13.
    View in: PubMed
  154. Farrag TY, Koch WM, Cummings CW, Goldenberg D, Abou-Jaoude PM, Califano JA, Flint PW, Webster K, Tufano RP. Supracricoid laryngectomy outcomes: The Johns Hopkins experience. Laryngoscope. 2007 Jan; 117(1):129-32.
    View in: PubMed
  155. Bhatti N, Mirski M, Tatlipinar A, Koch WM, Goldenberg D. Reduction of complication rate in percutaneous dilation tracheostomies. Laryngoscope. 2007 Jan; 117(1):172-5.
    View in: PubMed
  156. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park HL, Westra WH, Koch W, Sidransky D, Califano J. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer. 2006 Dec 1; 119(11):2673-6.
    View in: PubMed
  157. Goldenberg DM. Adjuvant and combined radioimmunotherapy: problems and prospects on the road to Minerva. J Nucl Med. 2006 Nov; 47(11):1746-8.
    View in: PubMed
  158. Goldenberg DM. Epratuzumab in the therapy of oncological and immunological diseases. Expert Rev Anticancer Ther. 2006 Oct; 6(10):1341-53.
    View in: PubMed
  159. Moosmayer D, Berndorff D, Chang CH, Sharkey RM, Rother A, Borkowski S, Rossi EA, McBride WJ, Cardillo TM, Goldenberg DM, Dinkelborg LM. Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors. Clin Cancer Res. 2006 Sep 15; 12(18):5587-95.
    View in: PubMed
  160. Waldman EH, Goldenberg D, Califano J, Sciubba J, Tunkel DE. Venous malformation of the sternomastoid muscle. Otolaryngol Head Neck Surg. 2006 Aug; 135(2):325-7.
    View in: PubMed
  161. Goldenberg D, Sciubba J, Koch WM. Cystic metastasis from head and neck squamous cell cancer: a distinct disease variant? Head Neck. 2006 Jul; 28(7):633-8.
    View in: PubMed
  162. Carnahan J, Stein R, Qu Z, Hess K, Cesano A, Hansen HJ, Goldenberg DM. Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Mol Immunol. 2007 Feb; 44(6):1331-41.
    View in: PubMed
  163. Stein R, Qu Z, Chen S, Solis D, Hansen HJ, Goldenberg DM. Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab. Blood. 2006 Oct 15; 108(8):2736-44.
    View in: PubMed
  164. Wolpoe ME, Goldenberg D, Koch WM. Squamous cell carcinoma of the sinonasal cavity arising as a second primary in individuals with head and neck cancer. Laryngoscope. 2006 May; 116(5):696-9.
    View in: PubMed
  165. Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Ferrer L, Faivre-Chauvet A, Campion L, Vuillez JP, Devillers A, Chang CH, Goldenberg DM, Chatal JF, Barbet J. Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. J Nucl Med. 2006 Feb; 47(2):247-55.
    View in: PubMed
  166. Sharkey RM, Goldenberg DM. Advances in radioimmunotherapy in the age of molecular engineering and pretargeting. Cancer Invest. 2006 Feb; 24(1):82-97.
    View in: PubMed
  167. Ha PK, Hdeib A, Goldenberg D, Jacene H, Patel P, Koch W, Califano J, Cummings CW, Flint PW, Wahl R, Tufano RP. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Jan; 132(1):12-6.
    View in: PubMed
  168. Goldenberg DM, Sharkey RM, Paganelli G, Barbet J, Chatal JF. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy. J Clin Oncol. 2006 Feb 10; 24(5):823-34.
    View in: PubMed
  169. Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol. 2006 Jan 10; 24(2):252-8.
    View in: PubMed
  170. Karacay H, Brard PY, Sharkey RM, Chang CH, Rossi EA, McBride WJ, Ragland DR, Horak ID, Goldenberg DM. Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograft. Clin Cancer Res. 2005 Nov 1; 11(21):7879-85.
    View in: PubMed
  171. Sharkey RM, Cardillo TM, Rossi EA, Chang CH, Karacay H, McBride WJ, Hansen HJ, Horak ID, Goldenberg DM. Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nat Med. 2005 Nov; 11(11):1250-5.
    View in: PubMed
  172. Koppe MJ, Oyen WJ, Bleichrodt RP, Hendriks T, Verhofstad AA, Goldenberg DM, Boerman OC. Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. Cancer Immunol Immunother. 2006 Jan; 55(1):47-55.
    View in: PubMed
  173. Blumenthal RD, Hansen HJ, Goldenberg DM. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res. 2005 Oct 1; 65(19):8809-17.
    View in: PubMed
  174. Sharkey RM, Karacay H, Cardillo TM, Chang CH, McBride WJ, Rossi EA, Horak ID, Goldenberg DM. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 2):7109s-7121s.
    View in: PubMed
  175. van Schaijk FG, Oosterwijk E, Soede AC, Broekema M, Frielink C, McBride WJ, Goldenberg DM, Corstens FH, Boerman OC. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 2):7130s-7136s.
    View in: PubMed
  176. Rossi EA, Chang CH, Losman MJ, Sharkey RM, Karacay H, McBride W, Cardillo TM, Hansen HJ, Qu Z, Horak ID, Goldenberg DM. Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 2):7122s-7129s.
    View in: PubMed
  177. Sapra P, Stein R, Pickett J, Qu Z, Govindan SV, Cardillo TM, Hansen HJ, Horak ID, Griffiths GL, Goldenberg DM. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys. Clin Cancer Res. 2005 Jul 15; 11(14):5257-64.
    View in: PubMed
  178. Lindén O, Hindorf C, Cavallin-Ståhl E, Wegener WA, Goldenberg DM, Horne H, Ohlsson T, Stenberg L, Strand SE, Tennvall J. Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab. Clin Cancer Res. 2005 Jul 15; 11(14):5215-22.
    View in: PubMed
  179. van Schaijk FG, Boerman OC, Soede AC, McBride WJ, Goldenberg DM, Corstens FH, Oosterwijk E. Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes. Eur J Nucl Med Mol Imaging. 2005 Sep; 32(9):1089-95.
    View in: PubMed
  180. Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM. Development of humanized antibodies as cancer therapeutics. Methods. 2005 May; 36(1):84-95.
    View in: PubMed
  181. Stein R, Govindan SV, Hayes M, Griffiths GL, Hansen HJ, Horak ID, Goldenberg DM. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody. Clin Cancer Res. 2005 Apr 1; 11(7):2727-34.
    View in: PubMed
  182. Masasyesva BG, Tong BC, Brock MV, Pilkington T, Goldenberg D, Sidransky D, Harden S, Westra WH, Califano J. Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer. Int J Cancer. 2005 Mar 1; 113(6):1022-5.
    View in: PubMed
  183. Golz A, Netzer A, Westerman ST, Westerman LM, Gilbert DA, Joachims HZ, Goldenberg D. Reading performance in children with otitis media. Otolaryngol Head Neck Surg. 2005 Mar; 132(3):495-9.
    View in: PubMed
  184. Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, Wahl R, Tufano RP. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope. 2005 Feb; 115(2):237-43.
    View in: PubMed
  185. Michel RB, Rosario AV, Andrews PM, Goldenberg DM, Mattes MJ. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):777-86.
    View in: PubMed
  186. Goldenberg D, Lee J, Koch WM, Kim MM, Trink B, Sidransky D, Moon CS. Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg. 2004 Dec; 131(6):986-93.
    View in: PubMed
  187. Stein R, Goldenberg DM. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. Mol Cancer Ther. 2004 Dec; 3(12):1559-64.
    View in: PubMed
  188. Modrak DE, Cardillo TM, Newsome GA, Goldenberg DM, Gold DV. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Res. 2004 Nov 15; 64(22):8405-10.
    View in: PubMed
  189. Goldenberg D, Rosenbaum E, Argani P, Wistuba II, Sidransky D, Thuluvath PJ, Hidalgo M, Califano J, Maitra A. The V599E BRAF mutation is uncommon in biliary tract cancers. Mod Pathol. 2004 Nov; 17(11):1386-91.
    View in: PubMed
  190. Ostrovsky D, Netzer A, Goldenberg D, Joachims HZ, Golz A. Delayed diagnosis of tracheoesophageal prosthesis aspiration. Ann Otol Rhinol Laryngol. 2004 Oct; 113(10):828-9.
    View in: PubMed
  191. Goldenberg D, Sciubba J, Koch W, Tufano RP. Malignant odontogenic tumors: a 22-year experience. Laryngoscope. 2004 Oct; 114(10):1770-4.
    View in: PubMed
  192. Burton JD, Ely S, Reddy PK, Stein R, Gold DV, Cardillo TM, Goldenberg DM. CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin Cancer Res. 2004 Oct 1; 10(19):6606-11.
    View in: PubMed
  193. Passalaqua AM, Klein RL, Wegener WA, Crawford JA, Crow JP, Andrews DA, Goldenberg DM. Diagnosing suspected acute nonclassic appendicitis with sulesomab, a radiolabeled antigranulocyte antibody imaging agent. J Pediatr Surg. 2004 Sep; 39(9):1338-44.
    View in: PubMed
  194. Stein R, Qu Z, Cardillo TM, Chen S, Rosario A, Horak ID, Hansen HJ, Goldenberg DM. Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Blood. 2004 Dec 1; 104(12):3705-11.
    View in: PubMed
  195. Goldenberg D, Benoit NE, Begum S, Westra WH, Cohen Y, Koch WM, Sidransky D, Califano JA. Epstein-Barr virus in head and neck cancer assessed by quantitative polymerase chain reaction. Laryngoscope. 2004 Jun; 114(6):1027-31.
    View in: PubMed
  196. Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O, Sidransky D, Westra WH. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res. 2004 May 15; 10(10):3444-7.
    View in: PubMed
  197. Cardillo TM, Karacay H, Goldenberg DM, Yeldell D, Chang CH, Modrak DE, Sharkey RM, Gold DV. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy. Clin Cancer Res. 2004 May 15; 10(10):3552-61.
    View in: PubMed
  198. Stein R, Qu Z, Chen S, Rosario A, Shi V, Hayes M, Horak ID, Hansen HJ, Goldenberg DM. Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma. Clin Cancer Res. 2004 Apr 15; 10(8):2868-78.
    View in: PubMed
  199. Goldenberg D, Sciubba J, Tufano RP. Odontogenic ghost cell carcinoma. Head Neck. 2004 Apr; 26(4):378-81.
    View in: PubMed
  200. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, Koch WM, Sidransky D, Califano JA. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004 Jan; 130(1):39-44.
    View in: PubMed
  201. Griffiths GL, Mattes MJ, Stein R, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM. Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate. Clin Cancer Res. 2003 Dec 15; 9(17):6567-71.
    View in: PubMed
  202. Rossi EA, Sharkey RM, McBride W, Karacay H, Zeng L, Hansen HJ, Goldenberg DM, Chang CH. Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 2):3886S-96S.
    View in: PubMed
  203. Kraeber-Bodéré F, Faivre-Chauvet A, Ferrer L, Vuillez JP, Brard PY, Rousseau C, Resche I, Devillers A, Laffont S, Bardiès M, Chang K, Sharkey RM, Goldenberg DM, Chatal JF, Barbet J. Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 2):3973S-81S.
    View in: PubMed
  204. Sharkey RM, Karacay H, Richel H, McBride WJ, Rossi EA, Chang K, Yeldell D, Griffiths GL, Hansen HJ, Goldenberg DM. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 2):3897S-913S.
    View in: PubMed
  205. Postema EJ, Raemaekers JM, Oyen WJ, Boerman OC, Mandigers CM, Goldenberg DM, van Dongen GA, Corstens FH. Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 2):3995S-4002S.
    View in: PubMed
  206. van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 2):3880S-5S.
    View in: PubMed
  207. Coleman M, Goldenberg DM, Siegel AB, Ketas JC, Ashe M, Fiore JM, Leonard JP. Epratuzumab: targeting B-cell malignancies through CD22. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 2):3991S-4S.
    View in: PubMed
  208. Gordin A, Ben-Arieh Y, Goldenberg D, Netzer A, Golz A. Extension of nasopharyngeal lymphoma to the middle and external ear. Ann Otol Rhinol Laryngol. 2003 Jul; 112(7):644-6.
    View in: PubMed
  209. Goldenberg D, Golz A, Joachims HZ. The beverage maté: a risk factor for cancer of the head and neck. Head Neck. 2003 Jul; 25(7):595-601.
    View in: PubMed
  210. Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Cesano A, Goldenberg DM. Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003 Aug 15; 21(16):3051-9.
    View in: PubMed
  211. Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D. Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol. 2003 Jul; 24(4):572-5.
    View in: PubMed
  212. Tsai DE, Maillard I, Schuster SJ, Nasta SD, Porter DL, Klumpp TR, Goldenberg DM, Luger SM, Alavi A, Sharkey RM, Hartzell KB, Stadtmauer EA. Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody. Clin Lymphoma. 2003 Jun; 4(1):56-9.
    View in: PubMed
  213. Golz A, Goldenberg D, Netzer A, Fradis M, Westerman ST, Westerman LM, Joachims HZ. Paper patching for chronic tympanic membrane perforations. Otolaryngol Head Neck Surg. 2003 Apr; 128(4):565-70.
    View in: PubMed
  214. Kaidar-Person O, Golz A, Netzer A, Goldsher D, Joachims HZ, Goldenberg D. Rapidly progressive bilateral sensory neural hearing loss as a presentation of mitochondrial neurogastrointestinal encephalomyopathy. Am J Otolaryngol. 2003 Mar-Apr; 24(2):128-30.
    View in: PubMed
  215. Goldenberg D, Golz A, Huri A, Netzer A, Joachims HZ, Bar-Lavie Y. Percutaneous dilation tracheotomy versus surgical tracheotomy: our experience. Otolaryngol Head Neck Surg. 2003 Mar; 128(3):358-63.
    View in: PubMed
  216. O'Hara JA, Blumenthal RD, Grinberg OY, Grinberg S, Wilmot C, Goldenberg DM, Swartz HM. Tumor pO2 assessments in human xenograft tumors measured by EPR oximetry: location of paramagnetic materials. Adv Exp Med Biol. 2003; 530:205-14.
    View in: PubMed
  217. Goldenberg D. Maté: a risk factor for oral and oropharyngeal cancer. Oral Oncol. 2002 Oct; 38(7):646-9.
    View in: PubMed
  218. Goldenberg D, Golz A, Netzer A, Joachims HZ. Tracheotomy: changing indications and a review of 1,130 cases. J Otolaryngol. 2002 Aug; 31(4):211-5.
    View in: PubMed
  219. Gordin A, Goldenberg D, Golz A, Netzer A, Joachims HZ. Magnesium: a new therapy for idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2002 Jul; 23(4):447-51.
    View in: PubMed
  220. Goldenberg D, Golz A, Netzer A, Joachims HZ. The use of otic powder in the treatment of acute external otitis. Am J Otolaryngol. 2002 May-Jun; 23(3):142-7.
    View in: PubMed
  221. Goldenberg DM. Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med. 2002 May; 43(5):693-713.
    View in: PubMed
  222. Blumenthal RD, Reising A, Leon E, Goldenberg DM. Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines. Clin Cancer Res. 2002 May; 8(5):1301-9.
    View in: PubMed
  223. Kairemo KJ, Lindahl H, Merenmies J, Föhr A, Nikkinen P, Karonen SL, Makipernaa A, Höckerstedt K, Goldenberg DM, Heikinheimo M. Anti-alpha-fetoprotein imaging is useful for staging hepatoblastoma. Transplantation. 2002 Apr 15; 73(7):1151-4.
    View in: PubMed
  224. Taylor AP, Osorio L, Craig R, Raleigh JA, Ying Z, Goldenberg DM, Blumenthal RD. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy. Clin Cancer Res. 2002 Apr; 8(4):1213-22.
    View in: PubMed
  225. Goldenberg DM. Eighth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Introduction. Cancer. 2002 Feb 15; 94(4 Suppl):1193-5.
    View in: PubMed
  226. Modrak DE, Rodriguez MD, Goldenberg DM, Lew W, Blumenthal RD. Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts. Int J Oncol. 2002 Feb; 20(2):379-84.
    View in: PubMed
  227. Netzer A, Golz A, Goldenberg D, Silberman M, Joachims HZ. Hyposmia following laryngectomy: experimental model. J Otolaryngol. 2002 Feb; 31(1):9-12.
    View in: PubMed
  228. Duek SD, Goldenberg D, Linn S, Krausz MM, Hershko DD. The role of fine-needle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg Today. 2002; 32(10):857-61.
    View in: PubMed
  229. Goldenberg D, Wenig BL. Telemedicine in otolaryngology. Am J Otolaryngol. 2002 Jan-Feb; 23(1):35-43.
    View in: PubMed
  230. Goldenberg D, Golz A, Netzer A, Flax-Goldenberg R, Joachims HZ. Synergistic necrotizing cellulitis as a complication of peritonsillar abscess. Am J Otolaryngol. 2001 Nov-Dec; 22(6):415-9.
    View in: PubMed
  231. Golz A, Netzer A, Goldenberg D, Westerman ST, Westerman LM, Joachims HZ. The association between iron-deficiency anemia and recurrent acute otitis media. Am J Otolaryngol. 2001 Nov-Dec; 22(6):391-4.
    View in: PubMed
  232. Blumenthal RD, Waskewich C, Goldenberg DM, Lew W, Flefleh C, Burton J. Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts. Clin Cancer Res. 2001 Oct; 7(10):3178-85.
    View in: PubMed
  233. Ochakovskaya R, Osorio L, Goldenberg DM, Mattes MJ. Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium. Clin Cancer Res. 2001 Jun; 7(6):1505-10.
    View in: PubMed
  234. Golz A, Westerman ST, Westerman LM, Goldenberg D, Netzer A, Wiedmyer T, Fradis M, Joachims HZ. The effects of noise on the vestibular system. Am J Otolaryngol. 2001 May-Jun; 22(3):190-6.
    View in: PubMed
  235. Goldenberg D, Golz A, Netzer A, Rosenblatt E, Rachmiel A, Goldenberg RF, Joachims HZ. Epstein-Barr virus and cancers of the head and neck. Am J Otolaryngol. 2001 May-Jun; 22(3):197-205.
    View in: PubMed
  236. Goldenberg D, Golz A, Fradis M, Mârtu D, Netzer A, Joachims HZ. Malignant tumors of the nose and paranasal sinuses: a retrospective review of 291 cases. Ear Nose Throat J. 2001 Apr; 80(4):272-7.
    View in: PubMed
  237. Golz A, Goldenberg D, Netzer A, Westerman ST, Joachims HZ. Epiglottic carcinoma presenting as obstructive sleep apnea. J Otolaryngol. 2001 Feb; 30(1):58-9.
    View in: PubMed
  238. Luntz M, Brodsky A, Nusem S, Kronenberg J, Keren G, Migirov L, Cohen D, Zohar S, Shapira A, Ophir D, Fishman G, Rosen G, Kisilevsky V, Magamse I, Zaaroura S, Joachims HZ, Goldenberg D. Acute mastoiditis--the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol. 2001 Jan; 57(1):1-9.
    View in: PubMed
  239. Ong GL, Elsamra SE, Goldenberg DM, Mattes MJ. Single-cell cytotoxicity with radiolabeled antibodies. Clin Cancer Res. 2001 Jan; 7(1):192-201.
    View in: PubMed
  240. Behr TM, Blumenthal RD, Memtsoudis S, Sharkey RM, Gratz S, Becker W, Goldenberg DM. Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments. Clin Cancer Res. 2000 Dec; 6(12):4900-7.
    View in: PubMed
  241. Golz A, Goldenberg D, Westerman ST, Catalfumo FJ, Netzer A, Westerman LM, Joachims HZ. Laser partial epiglottidectomy as a treatment for obstructive sleep apnea and laryngomalacia. Ann Otol Rhinol Laryngol. 2000 Dec; 109(12 Pt 1):1140-5.
    View in: PubMed
  242. Goldenberg D, Flax-Goldenberg R, Joachims HZ, Peled N. Misplaced parotid glands: bilateral agenesis of parotid glands associated with bilateral accessory parotid tissue. J Laryngol Otol. 2000 Nov; 114(11):883-5.
    View in: PubMed
  243. Lechner P, Lind P, Goldenberg DM. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival? J Am Coll Surg. 2000 Nov; 191(5):511-8.
    View in: PubMed
  244. Golz A, Goldenberg D, Ben-Arie Y, Keren R, Netzer A, Westerman ST, Joachims HZ. Basal cell adenocarcinoma of the parotid gland presenting as a retroauricular abscess. Am J Otolaryngol. 2000 Nov-Dec; 21(6):421-6.
    View in: PubMed
  245. Goldenberg D, Ari EG, Golz A, Danino J, Netzer A, Joachims HZ. Tracheotomy complications: a retrospective study of 1130 cases. Otolaryngol Head Neck Surg. 2000 Oct; 123(4):495-500.
    View in: PubMed
  246. Goldenberg D, Gilboa M, Danino J, Flax-Goldenberg R, Miller B, Joachims HZ. A large ethmoido-orbital osteoma presenting with epiphora in an 11-year-old boy. J Pediatr Ophthalmol Strabismus. 2000 Jul-Aug; 37(4):238-40.
    View in: PubMed
  247. Goldenberg DM, Abdel-Nabi H, Sullivan CL, Serafini A, Seldin D, Barron B, Lamki L, Line B, Wegener WA. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma. Cancer. 2000 Jul 1; 89(1):104-15.
    View in: PubMed
  248. Wegener WA, Petrelli N, Serafini A, Goldenberg DM. Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration. J Nucl Med. 2000 Jun; 41(6):1016-20.
    View in: PubMed
  249. Goldenberg D, Danino J, Netzer A, Joachims HZ. Plastipore implants in the surgical treatment of atrophic rhinitis: technique and results. Otolaryngol Head Neck Surg. 2000 Jun; 122(6):794-7.
    View in: PubMed
  250. Tsai DE, Schuster SJ, Matthies A, Moore HC, Alavi A, Juweid ME, Goldenberg DM, Stadtmauer EA. Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy. Clin Lymphoma. 2000 Jun; 1(1):62-6.
    View in: PubMed
  251. Goldenberg D, Karam M, Netzer A, Galamidi Z, Golz A, Golsovsky M, Joachims HZ. Facial vein thrombophlebitis: A rare but potentially lethal entity. Otolaryngol Head Neck Surg. 2000 May; 122(5):769-71.
    View in: PubMed
  252. Goldenberg D, Ardekian L, Rachmiel A, Peled M, Joachims HZ, Laufer D. Carcinoma of the dorsum of the tongue. Head Neck. 2000 Mar; 22(2):190-4.
    View in: PubMed
  253. Goldenberg D, Rachmiel A, Ben Yitzhak O, Peled M, Golz A, Laufer D, Joachims HZ. Triple primary malignancies of the head and neck. J Otolaryngol. 2000 Feb; 29(1):51-4.
    View in: PubMed
  254. Danino J, Goldenberg D, Joachims HZ. Submucosal arytenoidectomy: new surgical technique and review of the literature. J Otolaryngol. 2000 Feb; 29(1):13-6.
    View in: PubMed
  255. Goldenberg D, Flax-Goldenberg R, Joachims HZ, Peled N. Quiz case 1. Congenital nasal pyriform aperture stenosis (CNPAS). Arch Otolaryngol Head Neck Surg. 2000 Jan; 126(1):94, 96.
    View in: PubMed
  256. Goldenberg D, Golz A, Arie YB, Joachims HZ. Adenocarcinoma of the rectum with metastasis to the palatine tonsil. Otolaryngol Head Neck Surg. 1999 Nov; 121(5):653-4.
    View in: PubMed
  257. Stein R, Juweid M, Zhang CH, Goldenberg DM. Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3199s-3206s.
    View in: PubMed
  258. Ong GL, Goldenberg DM, Hansen HJ, Mattes MJ. Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines. Immunology. 1999 Oct; 98(2):296-302.
    View in: PubMed
  259. Juweid ME, Zhang CH, Blumenthal RD, Hajjar G, Sharkey RM, Goldenberg DM. Prediction of hematologic toxicity after radioimmunotherapy with (131)I-labeled anticarcinoembryonic antigen monoclonal antibodies. J Nucl Med. 1999 Oct; 40(10):1609-16.
    View in: PubMed
  260. Goldenberg DM. Introduction to the Seventh Conference on Radioimmunodetection and Radioimmunodetection and Radioimmunotherapy of Cancer. Clin Cancer Res. 1999 Oct; 5(10 Suppl):2991s.
    View in: PubMed
  261. Griffiths GL, Goldenberg DM, Roesch F, Hansen HJ. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3001s-3003s.
    View in: PubMed
  262. Qu Z, Losman MJ, Eliassen KC, Hansen HJ, Goldenberg DM, Leung SO. Humanization of Immu31, an alpha-fetoprotein-specific antibody. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3095s-3100s.
    View in: PubMed
  263. Burton J, Mishina D, Cardillo T, Lew K, Rubin A, Goldenberg DM, Gold DV. Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3065s-3072s.
    View in: PubMed
  264. Stein R, Govindan SV, Mattes MJ, Shih LB, Griffiths GL, Hansen HJ, Goldenberg DM. Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3079s-3087s.
    View in: PubMed
  265. Behr TM, Salib AL, Liersch T, Béhé M, Angerstein C, Blumenthal RD, Fayyazi A, Sharkey RM, Ringe B, Becker H, Wörmann B, Hiddemann W, Goldenberg DM, Becker W. Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3232s-3242s.
    View in: PubMed
  266. Leung SO, Qu Z, Hansen HJ, Shih LB, Wang J, Losman MJ, Goldenberg DM, Sharkey RM. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3106s-3117s.
    View in: PubMed
  267. Juweid ME, Stadtmauer E, Hajjar G, Sharkey RM, Suleiman S, Luger S, Swayne LC, Alavi A, Goldenberg DM. Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3292s-3303s.
    View in: PubMed
  268. Behr TM, Sgouros G, Stabin MG, Béhé M, Angerstein C, Blumenthal RD, Apostolidis C, Molinet R, Sharkey RM, Koch L, Goldenberg DM, Becker W. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3031s-3043s.
    View in: PubMed
  269. Losman MJ, Qu Z, Krishnan IS, Wang J, Hansen HJ, Goldenberg DM, Leung SO. Generation and monitoring of cell lines producing humanized antibodies. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3101s-3105s.
    View in: PubMed
  270. Behr TM, Wörmann B, Gramatzki M, Riggert J, Gratz S, Béhé M, Griesinger F, Sharkey RM, Kolb HJ, Hiddemann W, Goldenberg DM, Becker W. Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3304s-3314s.
    View in: PubMed
  271. Patel S, Stein R, Ong GL, Goldenberg DM, Mattes MJ. Enhancement of tumor-to-nontumor localization ratios by hepatocyte-directed blood clearance of antibodies labeled with certain residualizing radiolabels. J Nucl Med. 1999 Aug; 40(8):1392-401.
    View in: PubMed
  272. Golz A, Goldenberg D, Netzer A, Westerman LM, Westerman ST, Fradis M, Joachims HZ. Cholesteatomas associated with ventilation tube insertion. Arch Otolaryngol Head Neck Surg. 1999 Jul; 125(7):754-7.
    View in: PubMed
  273. Barron B, Hanna C, Passalaqua AM, Lamki L, Wegener WA, Goldenberg DM. Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium 99m-labeled antigranulocyte antibody Fab' fragment. LeukoScan Appendicitis Clinical Trial Group. Surgery. 1999 Mar; 125(3):288-96.
    View in: PubMed
  274. Goldenberg D, Karam M, Danino J, Flax-Goldenberg R, Joachims HZ. Temporal bone fracture following blunt trauma caused by a flying fish. J Laryngol Otol. 1998 Oct; 112(10):959-61.
    View in: PubMed
  275. Catalfumo FJ, Golz A, Westerman ST, Gilbert LM, Joachims HZ, Goldenberg D. The epiglottis and obstructive sleep apnoea syndrome. J Laryngol Otol. 1998 Oct; 112(10):940-3.
    View in: PubMed
  276. Reddy N, Ong GL, Behr TM, Sharkey RM, Goldenberg DM, Mattes MJ. Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations. Cancer Immunol Immunother. 1998 Mar; 46(1):25-33.
    View in: PubMed
  277. Juweid ME, Zhang CH, Blumenthal RD, Sharkey RM, Dunn R, Dunlop D, Goldenberg DM. Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodies. Cancer. 1997 Dec 15; 80(12 Suppl):2749-53.
    View in: PubMed
  278. Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Siegel JA, Becker WS, Goldenberg DM. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry. Cancer. 1997 Dec 15; 80(12 Suppl):2591-610.
    View in: PubMed
  279. Goldenberg DM. Perspectives on oncologic imaging with radiolabeled antibodies. Cancer. 1997 Dec 15; 80(12 Suppl):2431-5.
    View in: PubMed
  280. Blumenthal RD, Alisauskas R, Juweid M, Sharkey RM, Goldenberg DM. Defining the optimal spacing between repeat radioantibody doses in experimental models: is there an accurate measurement for hematopoietic recovery? Cancer. 1997 Dec 15; 80(12 Suppl):2624-35.
    View in: PubMed
  281. Goldenberg D, Golz A, Flax-Goldenberg R, Joachims HZ. Severe laryngeal injury caused by blunt trauma to the neck: a case report. J Laryngol Otol. 1997 Dec; 111(12):1174-6.
    View in: PubMed
  282. Stein R, Goldenberg DM, Ong GL, Thorpe SR, Mattes MJ. Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivo. J Nucl Med. 1997 Sep; 38(9):1392-400.
    View in: PubMed
  283. Blumenthal RD, Sharkey RM, Haywood L, Behr T, Goldenberg DM. Application of cytokine intervention for improved radio-antibody dose delivery. Int J Cancer. 1997 Jul 3; 72(1):166-73.
    View in: PubMed
  284. Dresel S, Kirsch CM, Tatsch K, Zachoval R, Hahn K, Goldenberg DM. Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit. J Clin Oncol. 1997 Jul; 15(7):2683-90.
    View in: PubMed
  285. Goldenberg D, Golz A, Joachims HZ. Retropharyngeal abscess: a clinical review. J Laryngol Otol. 1997 Jun; 111(6):546-50.
    View in: PubMed
  286. Behr TM, Sharkey RM, Juweid ME, Dunn RM, Vagg RC, Ying Z, Zhang CH, Swayne LC, Vardi Y, Siegel JA, Goldenberg DM. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. J Nucl Med. 1997 Jun; 38(6):858-70.
    View in: PubMed
  287. Mattes MJ, Shih LB, Govindan SV, Sharkey RM, Ong GL, Xuan H, Goldenberg DM. The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody. Int J Cancer. 1997 May 2; 71(3):429-35.
    View in: PubMed
  288. Behr TM, Goldenberg DM, Scheele JR, Wolf FG, Becker W. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods]. Dtsch Med Wochenschr. 1997 Apr 11; 122(15):463-70.
    View in: PubMed
  289. Goldenberg D, Gatot A, Barki Y, Leiberman A, Fliss DM. Computerized tomographic and ultrasonographic features of Kimura's disease. J Laryngol Otol. 1997 Apr; 111(4):389-91.
    View in: PubMed
  290. Behr TM, Sharkey RM, Juweid ME, Dunn RM, Ying Z, Zhang CH, Siegel JA, Goldenberg DM. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. J Nucl Med. 1997 Mar; 38(3):409-18.
    View in: PubMed
  291. Stein R, Goldenberg DM, Thorpe SR, Mattes MJ. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung. J Nucl Med. 1997 Mar; 38(3):391-5.
    View in: PubMed
  292. Juweid M, Sharkey RM, Alavi A, Swayne LC, Herskovic T, Hanley D, Rubin AD, Pereira M, Goldenberg DM. Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody. J Nucl Med. 1997 Feb; 38(2):257-60.
    View in: PubMed
  293. Goldenberg DM, Wegener W. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group. Acta Med Austriaca. 1997; 24(2):55-9.
    View in: PubMed
  294. Juweid ME, Sharkey RM, Behr T, Swayne LC, Dunn R, Siegel J, Goldenberg DM. Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. J Nucl Med. 1996 Sep; 37(9):1504-10.
    View in: PubMed
  295. Blumenthal RD, Stein R, Sharkey RM, Goldenberg DM, Ong GL, Klein KM, Mattes MJ. Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colon. Cancer Res. 1996 Aug 1; 56(15):3508-15.
    View in: PubMed
  296. Moffat FL, Pinsky CM, Hammershaimb L, Petrelli NJ, Patt YZ, Whaley FS, Goldenberg DM. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. J Clin Oncol. 1996 Aug; 14(8):2295-305.
    View in: PubMed
  297. Juweid M, Sharkey RM, Behr TM, Swayne LC, Dunn R, Ying Z, Siegel JA, Hansen HJ, Goldenberg DM. Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2. Cancer. 1996 Jul 1; 78(1):157-68.
    View in: PubMed
  298. Behr TM, Becker WS, Sharkey RM, Juweid ME, Dunn RM, Bair HJ, Wolf FG, Goldenberg DM. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J Nucl Med. 1996 May; 37(5):829-33.
    View in: PubMed
  299. Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Herskovic T, Hanley D, Markowitz A, Dunn R, Siegel J, Kamal T, Goldenberg DM. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J Clin Oncol. 1996 Apr; 14(4):1209-17.
    View in: PubMed
  300. Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer. Cancer Res. 1995 Dec 1; 55(23 Suppl):5857s-5863s.
    View in: PubMed
  301. Juweid M, Sharkey RM, Siegel JA, Behr T, Goldenberg DM. Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptake. Cancer Res. 1995 Dec 1; 55(23 Suppl):5827s-5831s.
    View in: PubMed
  302. Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Hanley D, Herskovic T, Markowitz A, Siegel J, Goldenberg DM. Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res. 1995 Dec 1; 55(23 Suppl):5946s-5951s.
    View in: PubMed
  303. Blend MJ, Hyun H, Kozloff M, Levi H, Mills GQ, Gasparini M, Buraggi G, Hughes L, Pinsky CM, Goldenberg DM. Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment. Cancer Res. 1995 Dec 1; 55(23 Suppl):5764s-5770s.
    View in: PubMed
  304. Becker WS, Behr TM, Cumme F, Rössler W, Wendler J, Kern PM, Gramatzki M, Kalden JR, Goldenberg DM, Wolf FG. 67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma. Cancer Res. 1995 Dec 1; 55(23 Suppl):5771s-5773s.
    View in: PubMed
  305. Blumenthal RD, Sharkey RM, Forman D, Wong G, Hess J, Goldenberg DM. Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantation. Exp Hematol. 1995 Sep; 23(10):1088-97.
    View in: PubMed
  306. Behr TM, Sharkey RM, Juweid ME, Blumenthal RD, Dunn RM, Griffiths GL, Bair HJ, Wolf FG, Becker WS, Goldenberg DM. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res. 1995 Sep 1; 55(17):3825-34.
    View in: PubMed
  307. Stein R, Goldenberg DM, Thorpe SR, Basu A, Mattes MJ. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. Cancer Res. 1995 Jul 15; 55(14):3132-9.
    View in: PubMed
  308. Kramer EL, Noz ME, Liebes L, Murthy S, Tiu S, Goldenberg DM. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results. Cancer. 1994 Feb 1; 73(3 Suppl):890-5.
    View in: PubMed
  309. Stein R, Basu A, Goldenberg DM, Lloyd KO, Mattes MJ. Characterization of cluster 13: the epithelial/carcinoma antigen recognized by MAb RS7. Int J Cancer Suppl. 1994; 8:98-102.
    View in: PubMed
  310. Goldenberg DM. Monoclonal antibodies in cancer detection and therapy. Am J Med. 1993 Mar; 94(3):297-312.
    View in: PubMed
  311. Stein R, Witz IP, Ovadia J, Goldenberg DM, Yron I. CD5+ B cells and naturally occurring autoantibodies in cancer patients. Clin Exp Immunol. 1991 Sep; 85(3):418-23.
    View in: PubMed
  312. Goldenberg DM, Horowitz JA, Sharkey RM, Hall TC, Murthy S, Goldenberg H, Lee RE, Stein R, Siegel JA, Izon DO, et al. Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol. 1991 Apr; 9(4):548-64.
    View in: PubMed
  313. Varadarajan A, Sharkey RM, Goldenberg DM, Hawthorne MF. Conjugation of phenyl isothiocyanate derivatives of carborane to antitumor antibody and in vivo localization of conjugates in nude mice. Bioconjug Chem. 1991 Mar-Apr; 2(2):102-10.
    View in: PubMed
  314. Goldenberg DM. Cancer imaging and therapy with radiolabeled antibodies. Adv Exp Med Biol. 1991; 303:107-17.
    View in: PubMed
  315. Goldenberg DM, Goldenberg H, Higginbotham-Ford E, Shochat D, Ruoslahti E. Imaging of primary and metastatic liver cancer with 131I monoclonal and polyclonal antibodies against alphafetoprotein. J Clin Oncol. 1987 Nov; 5(11):1827-35.
    View in: PubMed
  316. DeLand FH, Kim EE, Primus FJ, Dine ME, Goldenberg DM. In vivo radioimmunodetection of occult recurrent colonic carcinoma. AJR Am J Roentgenol. 1982 Jan; 138(1):145-8.
    View in: PubMed
  317. Hagihara PF, Yoneda K, Sachatello CR, Hedgecock H, Flesher JW, Ram MD, Griffen WO, Goldenberg DM. Colonic tumorigenesis in rats with 1,2-dimethylhydrazine. Dis Colon Rectum. 1980 Apr; 23(3):137-40.
    View in: PubMed
  318. Kim EE, Corgan RL, Casper S, Primus FJ, Spremulli E, Estes N, Goldenberg DM. Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer. J Nucl Med. 1979 Dec; 20(12):1243-50.
    View in: PubMed
  319. Donaldson E, Van Nagell JR, Wood EG, Pletsch Q, Goldenberg DM. Carcinoembryonic antigen in patients treated with radiation therapy for invasive squamous cell carcinoma of the uterine cervix. AJR Am J Roentgenol. 1976 Nov; 127(5):829-31.
    View in: PubMed
  320. Goldenberg DM, Pant KD. Host immunoreactivity to CSA, a tissue-specific antigen of normal and neoplastic human intestine. Adv Exp Med Biol. 1976; 73 Pt B:351-6.
    View in: PubMed
  321. Pletsch Q, Goldenberg DM. Molecular size of carcinoembryonic antigen in the plasma of patients with malignant disease. J Natl Cancer Inst. 1974 Nov; 53(5):1201-4.
    View in: PubMed
Goldenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_